Tasly Pharmaceutical Group Co., Ltd (600535.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.51B |
| Enterprise Value | 22.56B |
| P/E Ratio | 1.56 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 2.57 |
| Price/Book Ratio | 0.07 |
| Enterprise/Revenue | 2.52 |
| Enterprise/EBITDA | 10.95 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 8.24B |
| Revenue/Share | 131.19 |
| Gross Profit | 5.51B |
| EBITDA | 1.83B |
| Net Income | 1.11B |
| Diluted EPS | 0.74 |
Balance Sheet
| Total Cash | 4.02B |
| Total Cash/Share | 64.65 |
| Total Debt | 647.26M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 4.85 |
| Book Value Per Share | 213.23 |
Price History
| 52-Week Change | -13.88 |
| 52-Week High | 16.5 |
| 52-Week Low | 12.9 |
| Moving Average 50 Days | 15.14 |
| Moving Average 200 Days | 14.74 |
Statistics
| Average Volume | 16.7M |
| Shares Outstanding | 1.49B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.31 |
| Trailing Annual Dividend Yield | 2.21 |
| Payout Ratio | 0.39 |
| Last Split Factor | 7:5 |
| Last Split Date | June 05, 2018 |
AD
